← Back to Search
Genetic Variants Associated With Increased Risk Of Malignant Pleural Mesothelioma: A Genome-Wide Association Study
G. Matullo, S. Guarrera, M. Betti, G. Fiorito, D. Ferrante, Floriana Voglino, G. Cadby, C. Di Gaetano, F. Rosa, A. Russo, A. Hirvonen, E. Casalone, S. Tunesi, M. Padoan, M. Giordano, A. Aspesi, C. Casadio, F. Ardissone, E. Ruffini, P. Betta, R. Libener, R. Guaschino, E. Piccolini, M. Neri, A. Musk, N. de Klerk, J. Hui, J. Beilby, A. James, J. Creaney, B. Robinson, S. Mukherjee, L. Palmer, D. Mirabelli, D. Ugolini, S. Bonassi, C. Magnani, I. Dianzani
Published 2013 · Medicine
Download PDFAnalyze on Scholarcy
Asbestos exposure is the main risk factor for malignant pleural mesothelioma (MPM), a rare aggressive tumor. Nevertheless, only 5–17% of those exposed to asbestos develop MPM, suggesting the involvement of other environmental and genetic risk factors. To identify the genetic risk factors that may contribute to the development of MPM, we conducted a genome-wide association study (GWAS; 370,000 genotyped SNPs, 5 million imputed SNPs) in Italy, among 407 MPM cases and 389 controls with a complete history of asbestos exposure. A replication study was also undertaken and included 428 MPM cases and 1269 controls from Australia. Although no single marker reached the genome-wide significance threshold, several associations were supported by haplotype-, chromosomal region-, gene- and gene-ontology process-based analyses. Most of these SNPs were located in regions reported to harbor aberrant alterations in mesothelioma (SLC7A14, THRB, CEBP350, ADAMTS2, ETV1, PVT1 and MMP14 genes), causing at most a 2–3-fold increase in MPM risk. The Australian replication study showed significant associations in five of these chromosomal regions (3q26.2, 4q32.1, 7p22.2, 14q11.2, 15q14). Multivariate analysis suggested an independent contribution of 10 genetic variants, with an Area Under the ROC Curve (AUC) of 0.76 when only exposure and covariates were included in the model, and of 0.86 when the genetic component was also included, with a substantial increase of asbestos exposure risk estimation (odds ratio, OR: 45.28, 95% confidence interval, CI: 21.52–95.28). These results showed that genetic risk factors may play an additional role in the development of MPM, and that these should be taken into account to better estimate individual MPM risk in individuals who have been exposed to asbestos.
This paper references
Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24).
P. Lennon (2007)
Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma.
C. Lu (2011)
A Language and Environment for Statistical Computing. R Foundation for Statistical Computing
R Development (2009)
Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.
C. Storlazzi (2004)
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
Pvt1encoded microRNAs in oncogenesis
GB Beck-Engeser (2008)
A review of Human carcinogens: Metals, arsenic, dusts, and fibres. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Twelfth Edition
Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases.
M. Neri (2008)
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity.
Suzanne L. Topalian (2012)
Aberrant EVI 1 expression in acute myeloid leukemias associated with the t ( 3 ; 8 ) ( q 26 ; q 24 )
PA Lennon (2007)
Relaxin Promotes Prostate Cancer Progression
S. Feng (2007)
Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study.
I. Dianzani (2006)
A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
Bryan Howie (2009)
XRCC 1 and ERCC 1 variants modify malignant mesothelioma risk : A case - control study
M Betti (2011)
PRDM1 is a tumor suppressor gene in natural killer cell malignancies
Can Küçük (2011)
The CREST biorepository: a tool for molecular epidemiology and translational studies on malignant mesothelioma, lung cancer, and other respiratory tract diseases.
D. Ugolini (2008)
MYC on the Path to Cancer
C. Dang (2012)
Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer
Yinghui Guan (2007)
Principal components analysis corrects for stratification in genome-wide association studies
A. Price (2006)
Algorithm AS 136: A K-Means Clustering Algorithm
JA Hartigan (1979)
Germline BAP1 mutations predispose to malignant mesothelioma
J. Testa (2011)
Factors that Impact Susceptibility to Fiber-Induced Health Effects
J. Below (2011)
The European mesothelioma epidemic
J. Peto (1999)
GWAMA: software for genome-wide association meta-analysis
R. Mägi (2009)
The CREST Biorepository: A Tool for Molecular Epidemiology and Translational Studies on Malignant Mesothelioma, Lung Cancer, and Other Respiratory Tract Diseases
Ugolini Donatella (2008)
XRCC1 and ERCC1 variants modify malignant mesothelioma risk: a case-control study.
M. Betti (2011)
Mutation Research / Fundamental and Molecular Mechanisms of Mutagenesis
L. Migliore (2014)
The Thyroid Hormone Receptor Is a Suppressor of ras-Mediated Transcription, Proliferation, and Transformation
S. García-Silva (2004)
Genomic control for association studies.
B. Devlin (1999)
Genetic susceptibility to malignant mesothelioma and exposure to asbestos: the influence of the familial factor.
D. Ugolini (2008)
RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas.
Ernesta Fagiani (2007)
Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register.
A. Marinaccio (2007)
The Ubiquitin Carboxyl Hydrolase BAP1 Forms a Ternary Complex with YY1 and HCF-1 and Is a Critical Regulator of Gene Expression
Helen Yu (2010)
Pulmonary Endpoints (Lung Carcinomas and Asbestosis) Following Inhalation Exposure to Asbestos
B. Mossman (2011)
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma.
O. Melaiu (2012)
Measuring inconsistency in meta-analyses
J. Higgins (2003)
Thyroid hormone receptor beta1 acts as a potent suppressor of tumor invasiveness and metastasis.
O. Martínez-Iglesias (2009)
Relaxin promotes prostate cancer progression. Clinical cancer research : an official journal of the American Association for
S Feng (2007)
A k-means clustering algorithm
J. Hartigan (1979)
A Functional Variant at a Prostate Cancer Predisposition Locus at 8q24 Is Associated with PVT1 Expression
K. Meyer (2011)
The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24
K. Huppi (2008)
A new multipoint method for genome-wide association studies by imputation of genotypes
J. Marchini (2007)
Daughter Centriole Elongation Is Controlled by Proteolysis
N. Korzeniewski (2010)
Continuing increase in mesothelioma mortality in Britain
J. Peto (1995)
ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
Sangphil Oh (2012)
Double-minute MYC amplification and deletion of MTAP, CDKN2A, CDKN2B, and ELAVL2 in an acute myeloid leukemia characterized by oligonucleotide-array comparative genomic hybridization.
Anitha Kamath (2008)
A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres.
K. Straif (2009)
The Mesothelioma epidemic in Western Europe: an update
C. Pelucchi (2004)
Association between total number of deaths, diabetes mellitus, incident cancers, and haplotypes in chromosomal region 8q24 in a prospective study.
S. Guarrera (2012)
Pvt1-encoded microRNAs in oncogenesis
Gabriele B. Beck-Engeser (2007)
Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays
A. Dmitriev (2012)
Breakpoints of burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC
R. Zeidler (1994)
Risk assessment of lung cancer and asbestosis in workers exposed to asbestos fibers in brake shoe factory in Iran.
M. Azari (2010)
Clinicopathological Significance of Cell Cycle Regulatory Factors and Differentiation-Related Factors in Pancreatic Neoplasms
Yukinori Kamio (2010)
Genetic and epigenetic analysis of non-small cell lung cancer with NotImicroarrays
AA Dmitriev (2012)
Involvement of MRE11A and XPA gene polymorphisms in the modulation of DNA double-strand break repair activity: a genotype-phenotype correlation study.
F. Ricceri (2011)
Global Gene Expression Profiling Of Human Pleural Mesotheliomas: Identification of Matrix Metalloproteinase 14 (MMP-14) as Potential Tumour Target
S. Crispi (2009)
Characterization of FRA7B, a human common fragile site mapped at the 7p chromosome terminal region.
N. Bosco (2010)
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC
Nasim Ahmadiyeh (2010)
Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments.
Jonathan W. Wojtkowiak (2012)
A statistical method for region-based meta-analysis of genome-wide association studies in genetically diverse populations
X. Wang (2012)
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
Mitochondrial DNA variation of modern Tuscans supports the near eastern origin of Etruscans.
A. Achilli (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
Aravind Subramanian (2005)
The PVT‐1 oncogene is a Myc protein target that is overexpressed in transformed cells
Letizia Carramusa (2007)
In Arrayed Ranks: Array Technology in the Study of Mesothelioma
S. Gray (2009)
PLINK: a tool set for whole-genome association and population-based linkage analyses.
S. Purcell (2007)
Italy cases and review of the literature
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
A. Zuckerman (2010)
Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype
O. D. Røe (2009)
Advances in malignant mesothelioma.
B. Robinson (2005)
Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia
N. de Klerk (2013)
Adenovirus Type 5 E1A and E6 Proteins of Low-Risk Cutaneous Beta-Human Papillomaviruses Suppress Cell Transformation through Interaction with FOXK1/K2 Transcription Factors
J. Komorek (2010)
Asbestos--a legacy and a persistent problem.
F. Brims (2009)
Mesothelioma in blood related subjects: report of 11 clusters among 1954 Italy cases and review of the literature.
V. Ascoli (2007)
Cancer mortality in relation to measures of occupational exposure to crocidolite at Wittenoom Gorge in Western Australia.
N. de Klerk (1989)
Serum Mesothelin for Early Detection of Asbestos-Induced Cancer Malignant Mesothelioma
J. Creaney (2010)
This paper is referenced by
Familial malignant mesothelioma: a population-based study in central Italy (1980-2012).
V. Ascoli (2014)
MALIGNANT PLEURAL MESOTHELIOMA AND INFLAMMATION
The genetic susceptibility in the development of malignant pleural mesothelioma.
O. Melaiu (2018)
Impact of asbestos on public health: a retrospective study on a series of subjects with occupational and non-occupational exposure to asbestos during the activity of Fibronit plant (Broni, Italy)
S. Visonà (2018)
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos‐Exposed Subjects
S. Guarrera (2019)
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
M. Betti (2017)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma
V. Monica (2015)
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
I. Opitz (2020)
The Function and Roles of ADAMTS-7 in Inflammatory Diseases
Y. Zhang (2015)
Lung function not affected by asbestos exposure in workers with normal Computed Tomography scan
C. Schikowsky (2017)
Genetic predisposition for malignant mesothelioma: A concise review.
M. Betti (2019)
Gene-asbestos interaction in malignant pleural mesothelioma susceptibility.
S. Tunesi (2015)
Asbestos and the Pathophysiology of Mesothelioma
N. Zandwijk (2019)
The influence of selected polymorphisms in matrix metalloproteinases on response to treatment and disease progression in patients with mesothelioma
Danijela Štrbac (2019)
Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study
M. Lo Iacono (2015)
Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation
L. Ferrari (2020)
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high‐risk area
M. Betti (2015)
Association of melanoma with intraepithelial neoplasia of the pancreas in three patients.
Felipe Fidalgo (2014)
Novel Epigenetic Changes Unveiled by Monozygotic Twins Discordant for Smoking Habits
A. Allione (2015)
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
O. D. Røe (2015)
Genomics and Epigenetics of Malignant Mesothelioma
Adam P Sage (2018)
Chronic Inflammation in Malignant Mesothelioma Pathogenesis: Focus on HMGB1 Isoforms and Germline BAP1 Mutations
A. Napolitano (2015)
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes
M. Betti (2018)
Switching off malignant mesothelioma: exploiting the hypoxic microenvironment
Noushin Nabavi (2016)
Effect of insulin on the mRNA expression of procollagen N-proteinases in chondrosarcoma OUMS-27 cells.
S. Akyol (2015)
Genetics and Epigenetics of Mesothelioma
A. Aspesi (2019)
Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes
F. Celsi (2019)
Inherited Genetic Mutations and Polymorphisms in Malignant Mesothelioma: A Comprehensive Review
V. Panou (2020)
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues.
C. Magnani (2015)
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
V. Panou (2018)
Is DNA repair a potential target for effective therapies against malignant mesothelioma?
I. Fuso Nerini (2020)
New analysis framework incorporating mixed mutual information and scalable Bayesian networks for multimodal high dimensional genomic and epigenomic cancer data
Xichun Wang (2019)See more